Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0I3Q stock hub

LON/0I3Q has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0I3Qis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.1B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0I3Q

In the news

Latest news · LON/0I3Q

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E56.1

P25 12.9P50 16.9P75 23.5

Trailing P/E116.5

P25 15.9P50 22.9P75 35.8

ROE7.2

P25 -54.2P50 2.1P75 13.7

ROIC-2.8

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0I3Q market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

203

Groups with data

Currency

USD

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	730
Employees Change	148%
Employees Change Percent	42.05
Enterprise value	$3.7B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US2183521028
Last refreshed	2026-05-10
Market cap	$4.1B
Price	$52.45
Price currency	USD
Rev Per Employee	797,863.35x
Sector	Healthcare
Sic	2834
Symbol	lon/0I3Q
Website	https://www.corcept.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.86%
EV Earnings	106.01x
EV/FCF	41.19x
EV/Sales	6.64x
FCF yield	2.21%
Forward P/E	56.07x
P/B ratio	8.52x
P/E ratio	116.51x
P/S ratio	7.07x
PE Ratio10 Y	48.14x
PE Ratio3 Y	47.56x
PE Ratio5 Y	37.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-1.07%
EBITDA Margin	-0.9%
FCF margin	15.62%
Gross margin	98.25%
Gross Profit	$572.2M
Gross Profit Growth	12.08%
Gross Profit Growth Q	4.66%
Gross Profit Growth3 Y	22.78%
Gross Profit Growth5 Y	17.66%
Net Income	$35.4M
Net Income Growth	-64.67%
Net Income Growth Years	0%
Net Income Growth3 Y	-20.89%
Net Income Growth5 Y	-14.03%
Pretax Margin	1.58%
Profit Margin	6.16%
Profit Per Employee	$48,427
Profitable Years	10
ROA	-0.62
Roa5y	11.16
ROCE	-1.23
ROE	7.17
Roe5y	21.6
ROIC	-2.78
Roic5y	67.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-26.07%
Cagr3y	33.49%
Cagr5y	19.15%
EPS Growth	-64.81
EPS Growth Years	0
EPS Growth3 Y	-20.83
EPS Growth5 Y	-12.42
FCF Growth	-32.13%
FCF Growth3 Y	2.79%
FCF Growth5 Y	-3.4%
OCF Growth	-32.82%
OCF Growth10 Y	30.82%
OCF Growth3 Y	2.75%
OCF Growth5 Y	-3.52%
Revenue Growth	12.2x
Revenue Growth Q	4.89x
Revenue Growth Quarters	20x
Revenue Growth Years	13x
Revenue Growth3 Y	22.95x
Revenue Growth5 Y	17.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.93
Assets	$617.1M
Cash	$256.1M
Current Assets	$312.5M
Current Liabilities	$109.4M
Debt	$7.3M
Debt Equity	$0.02
Debt FCF	$0.08
Equity	$483.2M
Liabilities	$134M
Long Term Assets	$304.6M
Long Term Liabilities	$24.5M
Net Cash	$383.1M
Net Cash By Market Cap	$9.3
Net Cash Growth	-10.31%
Net Debt Equity	$-0.79
Net Debt FCF	$-4.21
Tangible Book Value	$483.2M
Tangible Book Value Per Share	$4.5
WACC	6.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.86
Inventory Turnover	0.99
Net Working Capital	$-45.2M
Quick ratio	2.53
Working Capital	$209.7M
Working Capital Turnover	$2.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.16%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-26.05%
200-day SMA	60.26
3Y total return	137.9%
50-day SMA	40.69
50-day SMA vs 200-day SMA	50under200
5Y total return	140.14%
All Time High	115.3
All Time High Change	-54.5%
All Time High Date	2025-04-01
All Time Low	11.31
All Time Low Change	363.92%
All Time Low Date	2019-07-30
ATR	2.28
Beta	0.36
Ch YTD	54.14
High	52.45
High52	91
High52 Date	2025-10-08
High52ch	-42.37%
Low	50.78
Low52	28.67
Low52 Date	2026-02-19
Low52ch	82.92%
Ma50ch	28.89%
Price vs 200-day SMA	-12.97%
RSI	70.54
RSI Monthly	50.38
RSI Weekly	52.12
Sharpe ratio	0.01x
Sortino ratio	0.07
Total Return	-0.16%
Tr YTD	54.14
Tr1m	26%
Tr1w	3.96%
Tr3m	31.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-6.2M
Operating margin	-1.07

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	88,902,256%
Shares Insiders	11.75%
Shares Institutions	66.11%
Shares Qo Q	-12.87%
Shares Yo Y	0.16%
Short Ratio	6.83

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$26.1M
Average Volume	615.8x
Bv Per Share	4.5
CAPEX	$-233,250
Ch1m	26
Ch1w	3.96
Ch1y	-26.05
Ch3m	31.91
Ch3y	137.9
Ch5y	140.1
Ch6m	-27.32
Change	3.87%
Change From Open	1.94
Close	50.49
Days Gap	1.9
Depreciation Amortization	942,565.5
Dollar Volume	15,733.7
Earnings Date	2026-04-30
EBIT	$-6.2M
EBITDA	$-5.3M
EPS	$0.3
F Score	4
FCF	$91M
FCF EV Yield	2.43x
Financing CF	-136,165,711
Fiscal Year End	December
Founded	1,998
Graham Number	7.89368
Graham Upside	-84.95
Income Tax	$-26.7M
Investing CF	58,669,176
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Lynch Fair Value	$2.25
Lynch Upside	-95.71
Ma150	56.11
Ma150ch	-6.53%
Ma20	47.11
Ma20ch	11.32%
Net CF	14,327,453
Open	51.45
P FCF Ratio	45.27
P OCF Ratio	45.15
Position In Range	99.75
Ppne	7,604,339.6
Price Date	2026-05-08
Ptbv Ratio	8.52
Relative Volume	0.44x
Revenue	582,440,246x
SBC By Revenue	11.14x
Share Based Comp	64,910,883
Tax By Revenue	-4.58x
Tr6m	-27.32%
Volume	300
Z Score	25.82

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0I3Q pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0I3Q stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0I3Q?

Insider, institutional, and short-interest positioning.

Institutional ownership

+66.1%

Share of float held by funds and institutions

Insider ownership

+11.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0I3Q momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

70.5

Above 70: short-term overbought

Price vs 200-day MA

-13.0%

50/200-day relationship not available

Beta (5Y)

0.35

Less volatile than the market

Sharpe ratio

0.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0I3Q

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0I3Q stock rating?

lon/0I3Q is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0I3Q analysis?

The full report lives at /stocks/lon/0I3Q/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0I3Q?

The latest report frames lon/0I3Q around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0I3Q page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.